Copyright
©2013 Baishideng Publishing Group Co.
World J Crit Care Med. Nov 4, 2013; 2(4): 48-55
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Figure 4 Immunohistochemical staining of tumor tissue.
Immunoreactivity for vascular endothelial growth factor (VEGF) was mainly identified as supranuclear staining or diffused staining in the cytoplasm of cancer cells. A: All 5 mice in the non-therapy group according to the percentage of positive tumor staining were in category 3, with 50% or more cells stained (VEGF, × 200); B: All 5 mice in the therapy group were in category 2, with 30 to 49% stained (VEGF, × 200).
- Citation: Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55
- URL: https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.48